Whitney & Co’s Athenahealth, Inc. ATHN Stock Holding History

Whitney & Co’s Portfolio ATHN Stock Details ATHN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-75	Closed	-$11K	–	345
2018 Q1	$11K	Buy	+75	New	+$10.2K	﹤0.01%	239

Other funds holding ATHN

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Whitney & Co's ATHN Position: Q2 2018 in Review

Whitney & Co sold out of Athenahealth, Inc. (ATHN) in Q2 2018, closing a stake of 75 shares — an estimated $11K sold.

Whitney & Co first reported a position in ATHN in Q1 2018 and held it in 1 quarter. The position peaked at $11K in Q1 2018. 275 funds tracked by Wall St. Rank hold ATHN as of Q2 2018.

Whitney & Co reported no remaining Athenahealth, Inc. position as of Q2 2018 after selling out during the quarter.
Whitney & Co sold 75 Athenahealth, Inc. shares in Q2 2018, an estimated $11K.
Whitney & Co first reported a position in Athenahealth, Inc. in Q1 2018 and held it in 1 quarter.
Whitney & Co's Athenahealth, Inc. position peaked at $11K in Q1 2018.
275 funds tracked by Wall St. Rank held Athenahealth, Inc. as of Q2 2018.

Based on Whitney & Co's 13F filing for Q2 2018, filed 14 Aug 2018.